Biofit 2010 - Fostering Innovation & Transfer

The successful 2010 edition:
the beginning of a long series…

Co-organized by IDIS and Eurasanté, the first edition of Biofit took place in the Northern France Bio-Cluster.
Biofit 2010 could not have been possible without the commitment of more than 50 sponsors and supporters who believed in this project since the beginning and supported its development.

Above all, the success of this new international event could not have been possible without the participation of all of you. The diversity and quality of your profiles combined with your involvement into the different activities offered made of Biofit 2010 a real success that will undoubtedly lead to major partnerships.

The 2010 edition is only the beginning of a long series, as this event will be rotating within the next years in other European biotech hotspots and will be back in Lille every four years.

We will let you know shortly the dates and venue of Biofit 2011!

Biofit 2010 Highlights

Academia ( TTOs and researchers in numerous aeras) presence: 41%

Biotechnology / Pharma : 37%

Middle and top management representives : Up to 37%

More than 1300 meetings scheduled

82 % of delegates are satisfied or very satisfied of the event (Content, organization, partnering, attendance, etc)

Conferences

Already renowned for the quality and diversity of its speakers, the Biofit conference program have been undoubtedly be one of the not-to-miss conferences of the year to explore hands-on approaches to technology transfer.

The themes of the eight conferences? Open Innovation, protecting and capitalizing on IP, managing the human resources in the new partnership models, finding financial support for collaborative projects…

To find the PowerPoint slideshows related to the conferences, click here

Presentations

To stimulate partnerships and tech transfer, the 20 “Presenting sessions” have been held by researchers, emerging life science companies and service providers.

To find the PowerPoint slideshows, click here

Stéphane DAVEZAC
Sales manager / IDIS
T: +33 1 40 09 68 74
sdavezac@biofit-event.com

Raphaël DESCHAMPS
Project manager / IDIS
T: +33 1 40 09 68 78
rdeschamps@biofit-event.com

Feedback

“I greatly enjoyed Biofit 2010”
Ashley J. Stevens, President, AUTM

“I really think this was a very promising start and I think that the angle you are taking with an emphasis on Open Innovation is to be applauded”
Margaret Beer, Senior Director and Head, Merck Sharp & Dohme

“The right size – It was possible to meet nearly every attendee in person. A great networking activity.”
Matthias Stein-Gerlach, Patent and Licensing Manager, Max-Planck Innovation

“I really believe that Biofit can become a valuable Conference and, find a place in the constellation”
Garold Breit, Executive Director, Technology Transfer Office, University of Manitoba

“Very strong focus on the interaction between technology transfer and industry with views from both sides”
Adrian Ibrahim, Associate Director, Cancer Research Technology Limited

"Right size for an interesting meeting"
Philippe Verwaerde, CEO, Alzprotect

"Great opportunity to meet TTOS and learn about new technology"
Vivienne Cox, Director, Bioscience Consultants

"Good panel sessions"
Robert Kirschbaum, VP Open Innovation, DSM

Major sponsor	Silver sponsor	Silver sponsor	Silver sponsor
Contributing sponsors	Contributing sponsors	Conference program sponsor

They were at Biofit 2010

Pharma

Abbott, Sanofi-Pasteur, MSD, Pfizer, Merck & Co, Merck Serono, Johnson & Johnson, DSM, TEVA, UCB, Les laboratoires Servier, Takeda, GlaxoSmithKline, Mérieux Development, Janssen Pharmaceuticals, Pierre Fabre, Laboratoires Fournier, LFB, Norgine, Mérieux Developpement...

Biotech

Ablynx, LFB, PXTherapeutic, Galapagos, Genfit, Debiopharm, Cytune Pharma, Genoscreen, Sigma-Aldrich, In cell Art, Plant Advanced Technologies, Algenics, BiolineRx, AbD Serotec, Novagraaf Technologies, Texcell, IdVectoR, Myosix, Delphi Genetics, Promethera Biosciences, Mellitech…

Academia

AUTM, Albert-Ludwigs-Universität Freiburg, Jagiellonian University, Geneva University, Leuven Catholic University, Academic medical center Amsterdam, Copenhagen University, Queen Mary Innovation Ltd, Pierre & Marie Curie University, Brussels University, Connectus, FIST, Netherlands Genomic Initiative, Boston University, Ghent University, Université Paris 11, Max Planck Innovation, Faculty of pharmacy of Lille, Université René Descartes - Faculty of Pharmacy, Conectus Alsace, Assistance Publique - Hôpitaux de Paris, Ifremer, Institut Curie, TTO Flanders, Cancer Research Technology Ltd, Max-Planck Innovation, Technion Technology Transfer, CEA, Royal Holloway University, University of Manitoba, Université de Liège Interface,etc.…

Service providers

Ascenion, IP Pragmatics, Licentia, Kurma Biofund, Burill &Company, 3M, KPMG, Vetter, Welience, Avenium consulting, Catalent Pharma, Bertin Pharma, FORENAP Pharma, AEPODIA, Bioceros, Sigma-Aldrich,…

SUPPORTERS		MEDIA SPONSOR
Assistance Publique – HOpitaux de Paris	APBio	Big Pharma Market
ASEBIO - Spanish Association of Bioenterprise	Adebag	Biofutur
Adebiotech	AlpsBiocluster	Bio-IT World
Ascenion	BIO Deutschland	Biotech Actors
Biowin	Club DEveloppeurs	Innovaro Pharmalicensing
EMBO	Entreprise Europe Network	Innovation & Industrie
European Biotechnology Network	Europharm SMC	La Gazette du Laboratoire
FlandersBio	GENT BC	Nature Events
GIS-IBISA	Hungarian Biotechnology Association	UniverCELLmarket
IC Strategy	Innoget
International Association of Science Parks - IASP	Licensing Executive Society
Lithuanian Biotech Association	One Nucleus
Life Science Austria	REseau Curie
Oxfordshire Bioscience Network	Shibuya
REseau Trans-tech	Technology Transfer office - University of Manitoba
The TBN Group